Experts call on FDA to provide greater clarity on its approach to AI
Regulatory NewsJoanne S. Eglovitch
Advertising, Promotion and LabelingArtificial intelligence/machine learning (AI/ML)Audit/inspectionCompliancePharmaceuticalsRegulatory harmonizationRegulatory Intelligence/PolicyRegulatory strategyUnited StatesUS Food and Drug Administration (FDA)